Insomnia
📧 Sign up to get email alerts when something new happens for Insomnia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2014-10-29FDA Approved: EDLUAR — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for EDLUAR (zolpidem tartrate) from Viatris Specialty LLC.
-
CLINICAL_TRIALS trial_result · 2014-10-15Clinical Trial Update: VEC-162 Study in Healthy Adult Volunteers in a Model of Insomnia [Phase 3]
Phase 3 trial of VEC-162 in healthy adults using an insomnia model has completed and results were posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-10-15Clinical Trial Update: VEC-162 Study in Adult Patients With Primary Insomnia [Phase 3]
Phase 3 trial update for VEC-162 in adults with primary insomnia; the study completed and results were posted in October 2014.
-
FDA approval · 2014-10-09FDA Approved: ULTRA SLEEP AID — Supplemental Application (Walgreen Company)
FDA approved a supplemental application for Ultra Sleep Aid, containing doxylamine succinate, submitted by Walgreens Company.
-
FDA approval · 2014-10-07FDA Approved: AMBIEN — Supplemental Application (Cosette Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Ambien (zolpidem tartrate) from Cosette Pharmaceuticals, Inc.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2014-10-07FDA Approved: ZOLPIDEM TARTRATE — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approved a supplemental application for zolpidem tartrate submitted by Sanofi-Aventis U.S. LLC, expanding the product's regulatory label…
-
CLINICAL_TRIALS trial_result · 2014-10-02Clinical Trial Update: Implementing Sleep Interventions for Older Veterans [NA]
Clinical trial about implementing sleep interventions for insomnia in older veterans has completed with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-09-25Clinical Trial Update: The Effect of Nasal Continuous Positive Airway Pressure Treatment on PTSD Symptoms.
This completed trial evaluated whether nasal CPAP improves PTSD symptoms and related sleep disturbances, including nightmares and unrefreshi…
-
FDA approval · 2014-09-18FDA Approved: HALCION — Supplemental Application (Pharmacia & Upjohn Company LLC)
FDA approved a supplemental application for Halcion (triazolam) from Pharmacia & Upjohn Company LLC.
-
CLINICAL_TRIALS trial_result · 2014-09-10Clinical Trial Update: A Study to Compare Efficacy and Safety of Zolpidem Modified Release Formulation Versus Zolpidem in Insomnia Patients [Phase 4]
This clinical trial compared the efficacy and safety of Zolpidem Modified Release versus standard Zolpidem in adults with insomnia; the Phas…
-
CLINICAL_TRIALS trial_result · 2014-09-10Clinical Trial Update: Effects of Suvorexant in Patients With Chronic Obstructive Pulmonary Disease (MK-4305-032) [Phase 1]
Phase 1 trial update on the effects of suvorexant in patients with chronic obstructive pulmonary disease (MK-4305-032) completed with result…
-
CLINICAL_TRIALS trial_result · 2014-09-09Clinical Trial Update: Effect of Rozerem on Sleep Among People With Traumatic Brain Injury [Phase 4]
This document provides an update on a Phase 4 trial evaluating ramelteon (Rozerem) for improving sleep in people with traumatic brain injury…
-
CLINICAL_TRIALS trial_result · 2014-09-05Clinical Trial Update: Sleep and Ventricular Arrhythmias Study [Phase 2]
A Phase 2 clinical trial evaluating sleep and ventricular arrhythmias in patients with cardiac arrhythmias who use implantable defibrillator…
-
CLINICAL_TRIALS trial_result · 2014-09-03Clinical Trial Update: Sleep to Lower Elevated Blood Pressure [NA]
A completed clinical trial investigated whether sleep interventions can lower elevated blood pressure in individuals with hypertension and s…
-
CLINICAL_TRIALS trial_result · 2014-09-01Clinical Trial Update: Safety and Efficacy Study of Suvorexant in Participants With Primary Insomnia - Study A (MK-4305-028) [Phase 3]
Phase 3 trial update on suvorexant for primary insomnia, reporting safety and efficacy results.
-
CLINICAL_TRIALS trial_result · 2014-09-01Clinical Trial Update: Safety and Efficacy Study of Suvorexant in Participants With Primary Insomnia - Study B (MK-4305-029) [Phase 3]
Phase 3 clinical trial update for suvorexant in primary insomnia; study completed with posted results in 2014.
-
CLINICAL_TRIALS trial_result · 2014-08-29Clinical Trial Update: A Long Term Safety Study of Suvorexant in Participants With Primary Insomnia (MK-4305-009 AM3) [Phase 3]
Phase 3 long-term safety study of suvorexant in participants with primary insomnia completed; results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-08-29Clinical Trial Update: Pharmacokinetics of Suvorexant in Participants With Impaired Renal Function (MK-4305-023)(COMPLETED) [Phase 1]
Phase 1 pharmacokinetics study evaluating suvorexant in participants with impaired renal function; completed with results posted.
-
CLINICAL_TRIALS trial_result · 2014-08-29Clinical Trial Update: Pharmacokinetics of Suvorexant in Participants With Hepatic Insufficiency (MK-4305-017) [Phase 1]
Phase 1 pharmacokinetics study of suvorexant in participants with hepatic insufficiency completed; assesses how liver impairment affects dru…
-
CLINICAL_TRIALS trial_result · 2014-08-22Clinical Trial Update: Lendormin D® Tablet (Drug Use Result Survey)
The clinical trial update indicates the study of Lendormin D Tablet for sleep initiation and maintenance disorders has completed.
-
CLINICAL_TRIALS trial_result · 2014-08-20Clinical Trial Update: A Double-blind, Group-comparison P-III Study With Zolpidem MR Using Placebo and Nitrazepam in Insomnia Patients [Phase 3]
A Phase 3 double-blind trial comparing zolpidem modified-release against placebo and nitrazepam in adults with insomnia has completed.
-
CLINICAL_TRIALS trial_result · 2014-08-20Clinical Trial Update: A Study of FK199B to Compare Efficacy With Zolpidem by Polysomnography in Patients With Insomnia [Phase 3]
A Phase 3 study comparing FK199B with zolpidem in patients with insomnia has completed, using polysomnography to assess efficacy.
-
CLINICAL_TRIALS trial_result · 2014-08-20Clinical Trial Update: A Double-blind, Group-comparison Study Using Zolpidem (Myslee) as a Comparative Drug in Patients With Insomnia [Phase 3]
Phase 3 double-blind, group-comparison trial uses Zolpidem (Myslee) as the comparator in patients with insomnia; the study status is complet…
-
CLINICAL_TRIALS trial_result · 2014-08-15Clinical Trial Update: Effects of Resistance Physical Exercise in Patients With Chronic Primary Insomnia [NA]
A completed clinical trial evaluating the effects of resistance physical exercise on chronic primary insomnia.
-
FDA approval · 2014-08-13FDA Approved: BELSOMRA — Original Application (Merck Sharp & Dohme LLC)
FDA approved BELSOMRA (suvorexant) as an original application for the treatment of insomnia in adults. BELSOMRA is a dual orexin receptor an…